236 related articles for article (PubMed ID: 26318837)
1. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
Teipel S; Drzezga A; Grothe MJ; Barthel H; Chételat G; Schuff N; Skudlarski P; Cavedo E; Frisoni GB; Hoffmann W; Thyrian JR; Fox C; Minoshima S; Sabri O; Fellgiebel A
Lancet Neurol; 2015 Oct; 14(10):1037-53. PubMed ID: 26318837
[TBL] [Abstract][Full Text] [Related]
2. Integrated multimodal imaging in neurodegenerative disease.
Grossman M
Lancet Neurol; 2015 Oct; 14(10):973-5. PubMed ID: 26318838
[No Abstract] [Full Text] [Related]
3. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
[TBL] [Abstract][Full Text] [Related]
5. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
Meiner Z; Rosenmann H
Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging in dementias.
de Souza LC; Lehéricy S; Dubois B; Stella F; Sarazin M
Curr Opin Psychiatry; 2012 Nov; 25(6):473-9. PubMed ID: 23037962
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
Masters CL; Cappai R; Barnham KJ; Villemagne VL
J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
[TBL] [Abstract][Full Text] [Related]
8. [Neuroimaging Alzheimer's disease: early diagnosis, monitoring, and mechanism understanding].
Chételat G
Med Sci (Paris); 2011 Feb; 27(2):193-8. PubMed ID: 21382329
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
[TBL] [Abstract][Full Text] [Related]
10. The development of effective biomarkers for Alzheimer's disease: a review.
Henry MS; Passmore AP; Todd S; McGuinness B; Craig D; Johnston JA
Int J Geriatr Psychiatry; 2013 Apr; 28(4):331-40. PubMed ID: 22674539
[TBL] [Abstract][Full Text] [Related]
11. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
12. Why musical memory can be preserved in advanced Alzheimer's disease.
Jacobsen JH; Stelzer J; Fritz TH; Chételat G; La Joie R; Turner R
Brain; 2015 Aug; 138(Pt 8):2438-50. PubMed ID: 26041611
[TBL] [Abstract][Full Text] [Related]
13. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
[TBL] [Abstract][Full Text] [Related]
14. Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.
Bagnoli S; Piaceri I; Sorbi S; Nacmias B
Neurodegener Dis Manag; 2014; 4(1):73-81. PubMed ID: 24640981
[TBL] [Abstract][Full Text] [Related]
15. Prospective interest of molecular neuroimaging in Alzheimer's disease.
Guedj E
Rev Neurol (Paris); 2013 Jan; 169(1):9-13. PubMed ID: 22682055
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.
Kantarci K
Expert Rev Neurother; 2005 Sep; 5(5):663-70. PubMed ID: 16162090
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for preclinical Alzheimer's disease.
Tan CC; Yu JT; Tan L
J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
[TBL] [Abstract][Full Text] [Related]
18. [MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].
Förstl H; Werheid K; Ulm K; Schönknecht P; Schmidt R; Pantel J; Hörr R; Gutzmann H; Gertz HJ; Frölich L; Bickel H
Dtsch Med Wochenschr; 2009 Jan; 134(3):88-91. PubMed ID: 19142839
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
